CAMLX
Price
$51.39
Change
+$0.67 (+1.32%)
Updated
Sep 17 closing price
Net Assets
570.62M
GFAFX
Price
$86.48
Change
+$1.09 (+1.28%)
Updated
Sep 17 closing price
Net Assets
353.07B
Interact to see
Advertisement

CAMLX vs GFAFX

CAMLX vs GFAFX Comparison Chart in %
View a ticker or compare two or three
VS
CAMLX vs. GFAFX commentary
Sep 18, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAMLX is a Hold and GFAFX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFAFX has more cash in the bank: 353B vs. CAMLX (571M). GFAFX pays higher dividends than CAMLX: GFAFX (0.20) vs CAMLX (0.00). CAMLX was incepted earlier than GFAFX: CAMLX (17 years) vs GFAFX (26 years). CAMLX (0.91) is less costly to investors than GFAFX (0.65). GFAFX is a more actively managed with annual turnover of: 32.00 vs. CAMLX (22.00). GFAFX has a lower initial minimum investment than CAMLX: GFAFX (250) vs CAMLX (2000). GFAFX annual gain was more profitable for investors over the last year : -0.50 vs. CAMLX (-1.50). GFAFX return over 5 years is better than : 12.54 vs. CAMLX (11.19).
CAMLXGFAFXCAMLX / GFAFX
Total Expense Ratio0.910.65140%
Annual Report Gross Expense Ratio0.910.65140%
Fund Existence17 years26 years-
Gain YTD4.2558.61649%
Front LoadN/AN/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets571M353B0%
Annual Yield % from dividends0.000.20-
Returns for 1 year-1.50-0.50296%
Returns for 3 years30.6943.5370%
Returns for 5 years11.1912.5489%
Returns for 10 years136.57103.86131%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ROFCX14.550.06
+0.41%
Royce Small-Cap Opportunity Consult
PAECX21.16N/A
N/A
Franklin Dynamic Asset Allocation Gr C
VLISX722.76N/A
N/A
Vanguard MStar Large Cap Index Instl
MDVSX9.76N/A
N/A
MassMutual Diversified Value R5
VVJEX12.11N/A
N/A
Voya VACS Series MCV Fund